|
|
Volumn 60, Issue 11, 2003, Pages 1873-1874
|
|
Prognosis for seizure recurrence in patients with newly diagnosed neurocysticercosis [6] (multiple letters)
a a a a a a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALBENDAZOLE;
ANTHELMINTIC AGENT;
ANTICONVULSIVE AGENT;
PARASITE ANTIBODY;
ANTICESTODAL AGENT;
ACUTE DISEASE;
ANTIBODY DETECTION;
BRAIN BIOPSY;
BRAIN METASTASIS;
CEREBROSPINAL FLUID SHUNTING;
CLINICAL FEATURE;
COMPUTER ASSISTED TOMOGRAPHY;
CYST;
DEGENERATION;
DIAGNOSTIC ACCURACY;
DIAGNOSTIC IMAGING;
DIAGNOSTIC PROCEDURE;
DIFFERENTIAL DIAGNOSIS;
DISEASE DURATION;
DRUG COST;
ENZYME IMMUNOASSAY;
EPILEPSY;
EPILEPTIC FOCUS;
FOLLOW UP;
GLIOMA;
HEADACHE;
HISTOPATHOLOGY;
HUMAN;
INDIA;
INFLAMMATION;
LETTER;
MEDICAL ETHICS;
METHODOLOGY;
NEUROCYSTICERCOSIS;
NEUROLOGIC DISEASE;
PRIORITY JOURNAL;
PROGNOSIS;
RANDOMIZATION;
RISK FACTOR;
SCOLEX;
SEIZURE;
SIDE EFFECT;
SURGICAL TECHNIQUE;
SYMPTOM;
TREATMENT OUTCOME;
TUBERCULOMA;
VISUAL IMPAIRMENT;
NOTE;
RECURRENT DISEASE;
ANTICESTODAL AGENTS;
HUMANS;
NEUROCYSTICERCOSIS;
PROGNOSIS;
RECURRENCE;
RISK FACTORS;
SEIZURES;
|
|
EID: 1542316786
PISSN: 00283878
EISSN: None
Source Type: Journal
DOI: 10.1212/WNL.60.11.1873 Document Type: Letter |
|
Times cited : (2)
|
|
References (0)
|